FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130557148> ?p ?o ?g. }

• W2130557148 endingPage "91" @default.
• W2130557148 startingPage "84" @default.
• W2130557148 abstract "Abstract Oxygen metabolism has an important role in the pathogenesis of rheumatoid arthritis. A certain correlation was observed between oxidative stress, arthritis and the immune system. Reactive oxygen species produced in the course of cellular oxidative phosphorylation and by activated phagocytic cells during oxidative burst, exceed the physiological buffering capacity and result in oxidative stress. The excessive production of ROS can damage protein, lipids, nucleic acids, and matrix components. Patients with rheumatoid arthritis have an altered antioxidant defense capacity barrier. In the present study the effect of substances with antioxidative properties, i.e. pinosylvin and carnosine, was determined in monotherapy for the treatment of adjuvant arthritis (AA). Moreover carnosine was evaluated in combination therapy with methotrexate. Rats with AA were administered first pinosylvin (30 mg/kg body mass daily per os ), second carnosine (150 mg/kg body mass daily per os ) in monotherapy for a period of 28 days. Further, rats with AA were administered methotrexate (0.3 mg/kg body mass 2-times weekly per os ), and a combination of methotrexate+carnosine, with the carnosine dose being the same as in the previous experiment. Parameters, i.e. changes in hind paw volume and arthritic score were determined in rats as indicators of destructive arthritis-associated clinical changes. Plasmatic levels of TBARS and lag time of Fe2+- induced lipid peroxidation (tau-FeLP) in plasma and brain were specified as markers of oxidation. Plasmatic level of CRP and activity of γ-glutamyltransferase (GGT) in spleen and joint were used as inflammation markers. In comparison to pinosylvin, administration of carnosine monotherapy led to a significant decrease in the majority of the parameters studied. In the combination treatment with methotrexate+carnosine most parameters monitored were improved more remarkably than by methotrexate alone. Carnosine can increase the disease-modifying effect of methotrexate treatment in rat AA." @default.
• W2130557148 created "2016-06-24" @default.
• W2130557148 creator A5014341769 @default.
• W2130557148 creator A5015377008 @default.
• W2130557148 creator A5019439623 @default.
• W2130557148 creator A5039766886 @default.
• W2130557148 creator A5050846282 @default.
• W2130557148 creator A5068413199 @default.
• W2130557148 creator A5081005362 @default.
• W2130557148 creator A5090585725 @default.
• W2130557148 date "2012-11-09" @default.
• W2130557148 modified "2023-10-01" @default.
• W2130557148 title "Pharmacological influence on processes of adjuvant arthritis: effect of the combination of an antioxidant active substance with methotrexate" @default.
• W2130557148 cites W101259488 @default.
• W2130557148 cites W1262158971 @default.
• W2130557148 cites W151794463 @default.
• W2130557148 cites W1866639487 @default.
• W2130557148 cites W1964336741 @default.
• W2130557148 cites W1964613505 @default.
• W2130557148 cites W1971144734 @default.
• W2130557148 cites W1976765131 @default.
• W2130557148 cites W1990761779 @default.
• W2130557148 cites W1996479055 @default.
• W2130557148 cites W1998292223 @default.
• W2130557148 cites W2000731411 @default.
• W2130557148 cites W2010929640 @default.
• W2130557148 cites W2015239879 @default.
• W2130557148 cites W2019448678 @default.
• W2130557148 cites W2035054007 @default.
• W2130557148 cites W2047606314 @default.
• W2130557148 cites W2047789654 @default.
• W2130557148 cites W2052562838 @default.
• W2130557148 cites W2056160571 @default.
• W2130557148 cites W2057028002 @default.
• W2130557148 cites W2062285406 @default.
• W2130557148 cites W2067068975 @default.
• W2130557148 cites W2070468924 @default.
• W2130557148 cites W2076470857 @default.
• W2130557148 cites W2080265410 @default.
• W2130557148 cites W2102172521 @default.
• W2130557148 cites W2123238252 @default.
• W2130557148 cites W2149745468 @default.
• W2130557148 cites W2152348310 @default.
• W2130557148 cites W2165689497 @default.
• W2130557148 cites W2170222601 @default.
• W2130557148 cites W2409065098 @default.
• W2130557148 cites W2415212483 @default.
• W2130557148 cites W2429542833 @default.
• W2130557148 cites W50095886 @default.
• W2130557148 cites W93019391 @default.
• W2130557148 cites W2003741937 @default.
• W2130557148 cites W46650105 @default.
• W2130557148 doi "https://doi.org/10.2478/v10102-012-0015-4" @default.
• W2130557148 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3485659" @default.
• W2130557148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23118593" @default.
• W2130557148 hasPublicationYear "2012" @default.
• W2130557148 type Work @default.
• W2130557148 sameAs 2130557148 @default.
• W2130557148 citedByCount "14" @default.
• W2130557148 countsByYear W21305571482013 @default.
• W2130557148 countsByYear W21305571482014 @default.
• W2130557148 countsByYear W21305571482015 @default.
• W2130557148 countsByYear W21305571482016 @default.
• W2130557148 countsByYear W21305571482019 @default.
• W2130557148 countsByYear W21305571482020 @default.
• W2130557148 countsByYear W21305571482021 @default.
• W2130557148 countsByYear W21305571482022 @default.
• W2130557148 countsByYear W21305571482023 @default.
• W2130557148 crossrefType "journal-article" @default.
• W2130557148 hasAuthorship W2130557148A5014341769 @default.
• W2130557148 hasAuthorship W2130557148A5015377008 @default.
• W2130557148 hasAuthorship W2130557148A5019439623 @default.
• W2130557148 hasAuthorship W2130557148A5039766886 @default.
• W2130557148 hasAuthorship W2130557148A5050846282 @default.
• W2130557148 hasAuthorship W2130557148A5068413199 @default.
• W2130557148 hasAuthorship W2130557148A5081005362 @default.
• W2130557148 hasAuthorship W2130557148A5090585725 @default.
• W2130557148 hasBestOaLocation W21305571481 @default.
• W2130557148 hasConcept C126322002 @default.
• W2130557148 hasConcept C185592680 @default.
• W2130557148 hasConcept C203014093 @default.
• W2130557148 hasConcept C2776151105 @default.
• W2130557148 hasConcept C2776914184 @default.
• W2130557148 hasConcept C2777077863 @default.
• W2130557148 hasConcept C2777575956 @default.
• W2130557148 hasConcept C2778004101 @default.
• W2130557148 hasConcept C2780687331 @default.
• W2130557148 hasConcept C2780829032 @default.
• W2130557148 hasConcept C2781059491 @default.
• W2130557148 hasConcept C48349386 @default.
• W2130557148 hasConcept C55493867 @default.
• W2130557148 hasConcept C71924100 @default.
• W2130557148 hasConcept C98274493 @default.
• W2130557148 hasConceptScore W2130557148C126322002 @default.
• W2130557148 hasConceptScore W2130557148C185592680 @default.
• W2130557148 hasConceptScore W2130557148C203014093 @default.
• W2130557148 hasConceptScore W2130557148C2776151105 @default.
• W2130557148 hasConceptScore W2130557148C2776914184 @default.

• next